Wolverine Trading’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.56M | Sell |
10,400
-700
| -6% | -$425K | ﹤0.01% | 1197 |
|
|
2025
Q2 | $5.9M | Buy |
11,100
+5,800
| +109% | +$2.77M | 0.01% | 969 |
|
|
2025
Q1 | $2.2M | Sell |
5,300
-7,700
| -59% | -$3.34M | ﹤0.01% | 1553 |
|
|
2024
Q4 | $5.37M | Buy |
13,000
+1,500
| +13% | +$658K | 0.01% | 1152 |
|
|
2024
Q3 | $5.89M | Buy |
11,500
+7,700
| +203% | +$3.74M | 0.01% | 931 |
|
|
2024
Q2 | $1.85M | Sell |
3,800
-600
| -14% | -$301K | ﹤0.01% | 1668 |
|
|
2024
Q1 | $2.38M | Sell |
4,400
-3,100
| -41% | -$1.69M | ﹤0.01% | 1479 |
|
|
2023
Q4 | $4.16M | Buy |
7,500
+1,300
| +21% | +$610K | ﹤0.01% | 1218 |
|
|
2023
Q3 | $2.71M | Buy |
6,200
+600
| +11% | +$299K | ﹤0.01% | 1372 |
|
|
2023
Q2 | $2.77M | Sell |
5,600
-2,200
| -28% | -$1.05M | ﹤0.01% | 1283 |
|
|
2023
Q1 | $3.85M | Sell |
7,800
-1,700
| -18% | -$814K | 0.01% | 976 |
|
|
2022
Q4 | $3.88M | Buy |
9,500
+4,400
| +86% | +$1.71M | 0.01% | 1025 |
|
|
2022
Q3 | $1.69M | Sell |
5,100
-600
| -11% | -$220K | ﹤0.01% | 1534 |
|
|
2022
Q2 | $2.04M | Sell |
5,700
-1,700
| -23% | -$693K | ﹤0.01% | 1364 |
|
|
2022
Q1 | $4.06M | Sell |
7,400
-1,100
| -13% | -$579K | 0.01% | 1207 |
|
|
2021
Q4 | $5.62M | Sell |
8,500
-2,900
| -25% | -$1.82M | 0.01% | 1079 |
|
|
2021
Q3 | $7.18M | Buy |
11,400
+3,300
| +41% | +$2.22M | 0.01% | 1035 |
|
|
2021
Q2 | $5.16M | Sell |
8,100
-2,100
| -21% | -$1.16M | 0.01% | 1112 |
|
|
2021
Q1 | $4.86M | Buy |
10,200
+6,200
| +155% | +$3.11M | 0.01% | 1136 |
|
|
2020
Q4 | $1.99M | Sell |
4,000
-3,400
| -46% | -$1.52M | ﹤0.01% | 1711 |
|
|
2020
Q3 | $2.85M | Sell |
7,400
-1,800
| -20% | -$665K | 0.01% | 1210 |
|
|
2020
Q2 | $3.02M | Sell |
9,200
-4,400
| -32% | -$1.27M | 0.01% | 1118 |
|
|
2020
Q1 | $3.28M | Buy |
13,600
+2,800
| +26% | +$731K | 0.01% | 993 |
|
|
2019
Q4 | $2.83M | Sell |
10,800
-10,200
| -49% | -$2.69M | 0.01% | 1553 |
|
|
2019
Q3 | $5.72M | Buy |
+21,000
| New | +$5.84M | 0.02% | 795 |
|
|
2019
Q2 | – | Sell |
-33,000
| Closed | -$7.38M | – | 4754 |
|
|
2019
Q1 | $7.38M | Buy |
33,000
+5,500
| +20% | +$1.14M | 0.02% | 652 |
|
|
2018
Q4 | $5.11M | Buy |
27,500
+12,100
| +79% | +$2.48M | 0.01% | 799 |
|
|
2018
Q3 | $3.85M | Sell |
15,400
-600
| -4% | -$146K | 0.01% | 1153 |
|
|
2018
Q2 | $3.06M | Hold |
16,000
| – | – | 0.01% | 1236 |
|
|
2018
Q1 | $3.06M | Sell |
16,000
-600
| -4% | -$111K | 0.01% | 1236 |
|
|
2017
Q4 | $2.6M | Sell |
16,600
-4,500
| -21% | -$708K | 0.01% | 1332 |
|
|
2017
Q3 | $3.28M | Sell |
21,100
-700
| -3% | -$111K | 0.01% | 1018 |
|
|
2017
Q2 | $3.5M | Buy |
+21,800
| New | +$3.54M | 0.02% | 881 |
|
|
2017
Q1 | – | Sell |
-9,800
| Closed | -$1.15M | – | 4602 |
|
|
2016
Q4 | $1.15M | Sell |
9,800
-6,300
| -39% | -$719K | 0.01% | 1784 |
|
|
2016
Q3 | $1.8M | Buy |
16,100
+6,700
| +71% | +$706K | 0.01% | 1385 |
|
|
2016
Q2 | $856K | Buy |
+9,400
| New | +$807K | ﹤0.01% | 1728 |
|
Other funds holding IDXX
Wolverine Trading's IDXX Position: Q3 2025 in Review
Wolverine Trading opened a new position in Idexx Laboratories (IDXX) in Q3 2025: 3,245 shares worth $2.05M. The stake represents ﹤0.01% of the portfolio and ranks #2165 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IDXX as recently as Q1 2025.
Wolverine Trading first reported a position in IDXX in Q2 2016 and has held it in 25 quarters since. The position peaked at $2.67M in Q4 2019. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.
- Wolverine Trading held 3,245 shares of Idexx Laboratories worth $2.05M as of Q3 2025.
- Idexx Laboratories was a new Wolverine Trading position in Q3 2025.
- Idexx Laboratories made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2165 holding.
- Wolverine Trading first reported a position in Idexx Laboratories in Q2 2016 and has held it in 25 quarters since.
- Wolverine Trading's Idexx Laboratories position peaked at $2.67M in Q4 2019.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.